Department of Medical and Surgical Sciences, IV Surgical Clinic, University of Padova, Ospedale Giustinianeo, Via Giustiniani 2, 35128 Padua, Italy.
J Hepatobiliary Pancreat Sci. 2011 Jan;18(1):94-102. doi: 10.1007/s00534-010-0317-x.
BACKGROUND/PURPOSE: Pylorus-preserving pancreaticoduodenectomy (PPPD) is the treatment of choice for benign or premalignant pancreatic head lesions. Duodenum-preserving pancreatic head resection (DPPHR) has been reported in only 132 patients. This study aimed to compare the long-term results of DPPHR and PPPD.
Patients who underwent DPPHR or PPPD for benign or borderline disease between 1991 and 2008 were followed up until December 2009 or their death. Endocrine and exocrine pancreatic functions were evaluated at their last follow-up.
Twenty-seven patients underwent DPPHR (Group 1) and 37 PPPD (Group 2). They were followed for a mean of 100 and 135 months, respectively. Group 1 had a higher complication rate (81.5 vs. 40.5%) and pancreatic fistula rate (40.1 vs. 18.9%). Hospital mortality was 0 and 2.7%, respectively. Two patients died 3.3 and 97 months after DPPHR. Significantly more Group 2 patients needed medical treatment for benign cholangitis (P < 0.0001). Insulin-dependent diabetes mellitus was observed in six Group 1 and 15 Group 2 patients (P = 0.077). Ten Group 1 and 21 Group 2 patients are taking pancreatic enzymes (P = 0.003).
DPPHR for benign or premalignant lesions is a difficult procedure with a higher complication rate than PPPD, but was without mortality. Preserving the entire duodenum and a normal biliary tree allows better long-term results.
背景/目的:保留幽门的胰十二指肠切除术(PPPD)是治疗良性或交界性胰头病变的首选方法。保留十二指肠的胰头切除术(DPPHR)仅在 132 例患者中报告过。本研究旨在比较 DPPHR 和 PPPD 的长期结果。
1991 年至 2008 年间,对良性或交界性疾病行 DPPHR 或 PPPD 的患者进行随访,随访至 2009 年 12 月或死亡。在最后一次随访时评估内分泌和外分泌胰腺功能。
27 例行 DPPHR(组 1)和 37 例行 PPPD(组 2)。两组分别平均随访 100 个月和 135 个月。组 1的并发症发生率(81.5%比 40.5%)和胰瘘发生率(40.1%比 18.9%)较高。住院死亡率分别为 0%和 2.7%。2 例患者分别在 DPPHR 后 3.3 个月和 97 个月死亡。组 2 中有更多患者需要药物治疗良性胆管炎(P<0.0001)。组 1 中有 6 例和组 2 中有 15 例患者发生胰岛素依赖型糖尿病(P=0.077)。组 1 中有 10 例和组 2 中有 21 例患者服用胰酶(P=0.003)。
DPPHR 治疗良性或交界性病变是一种困难的手术,其并发症发生率高于 PPPD,但无死亡率。保留整个十二指肠和正常胆道可获得更好的长期结果。